Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TISAGENLECLEUCEL for Diffuse large b-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 1,321 adverse event reports in the FDA FAERS database where TISAGENLECLEUCEL was used for Diffuse large b-cell lymphoma.

Most Reported Side Effects for TISAGENLECLEUCEL

Side Effect Reports % Deaths Hosp.
Cytokine release syndrome 1,660 39.3% 505 696
Pyrexia 1,030 24.4% 311 427
Malignant neoplasm progression 582 13.8% 400 126
Hypotension 425 10.1% 156 214
Immune effector cell-associated neurotoxicity syndrome 416 9.8% 127 183
Neurotoxicity 411 9.7% 146 155
Platelet count decreased 397 9.4% 182 77
White blood cell count decreased 392 9.3% 164 59
Hypogammaglobulinaemia 374 8.8% 126 38
Lymphocyte count decreased 365 8.6% 139 38
Acute lymphocytic leukaemia recurrent 361 8.5% 100 71
Neutrophil count decreased 358 8.5% 134 58
Haemoglobin decreased 356 8.4% 175 47
Diffuse large b-cell lymphoma 300 7.1% 229 69
Death 282 6.7% 282 30

Other Indications for TISAGENLECLEUCEL

Acute lymphocytic leukaemia (928) Product used for unknown indication (494) B-cell type acute leukaemia (354) Acute lymphocytic leukaemia recurrent (225) Diffuse large b-cell lymphoma recurrent (118) B-cell lymphoma (87) Non-hodgkin's lymphoma (86) Follicular lymphoma (82) Diffuse large b-cell lymphoma refractory (72) Lymphoma (61)

Other Drugs Used for Diffuse large b-cell lymphoma

RITUXIMAB (22,275) CYCLOPHOSPHAMIDE (16,598) DOXORUBICIN (15,213) VINCRISTINE (14,922) PREDNISONE (11,266) LENALIDOMIDE (7,858) ETOPOSIDE (4,698) PREDNISOLONE (4,086) CYTARABINE (3,857) DEXAMETHASONE (3,696)

Related Pages

TISAGENLECLEUCEL Full Profile All Diffuse large b-cell lymphoma Drugs TISAGENLECLEUCEL Demographics TISAGENLECLEUCEL Timeline